Meet the 30 biotech leaders under 40 who are searching for breakthrough treatments and shaping the future of medicine
It’s an exciting time to be in the biotech and pharmaceutical industries. To read the full piece, please click here.
Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.